Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, Yabe D, Nishimura R, Harada N, Kamiya H, Suzuki R, Yamauchi T. Bouchi R, et al. Among authors: harada n. Diabetol Int. 2022 Dec 23;14(1):1-14. doi: 10.1007/s13340-022-00605-x. eCollection 2023 Jan. Diabetol Int. 2022. PMID: 36636161 Free PMC article. No abstract available.
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
Himeno T, Kamiya H, Naruse K, Harada N, Ozaki N, Seino Y, Shibata T, Kondo M, Kato J, Okawa T, Fukami A, Hamada Y, Inagaki N, Seino Y, Drucker DJ, Oiso Y, Nakamura J. Himeno T, et al. Among authors: harada n. Diabetes. 2011 Sep;60(9):2397-406. doi: 10.2337/db10-1462. Epub 2011 Aug 1. Diabetes. 2011. PMID: 21810596 Free PMC article.
Self-monitoring of blood glucose (SMBG) improves glycaemic control in oral hypoglycaemic agent (OHA)-treated type 2 diabetes (SMBG-OHA study).
Harashima S, Fukushima T, Sasaki M, Nishi Y, Fujimoto S, Ogura M, Yamane S, Tanaka D, Harada N, Hamasaki A, Nagashima K, Nakahigashi Y, Seino Y, Inagaki N. Harashima S, et al. Among authors: harada n. Diabetes Metab Res Rev. 2013 Jan;29(1):77-84. doi: 10.1002/dmrr.2363. Diabetes Metab Res Rev. 2013. PMID: 23008090 Clinical Trial.
Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretion.
Sakamoto E, Seino Y, Fukami A, Mizutani N, Tsunekawa S, Ishikawa K, Ogata H, Uenishi E, Kamiya H, Hamada Y, Sato H, Harada N, Toyoda Y, Miwa I, Nakamura J, Inagaki N, Oiso Y, Ozaki N. Sakamoto E, et al. Among authors: harada n. J Diabetes Investig. 2012 Oct 18;3(5):432-40. doi: 10.1111/j.2040-1124.2012.00208.x. J Diabetes Investig. 2012. PMID: 24843603 Free PMC article.
Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients.
Yabe D, Kuroe A, Watanabe K, Iwasaki M, Hamasaki A, Hamamoto Y, Harada N, Yamane S, Lee S, Murotani K, Deacon CF, Holst JJ, Hirano T, Inagaki N, Kurose T, Seino Y. Yabe D, et al. Among authors: harada n. J Diabetes Complications. 2015 Apr;29(3):413-21. doi: 10.1016/j.jdiacomp.2014.12.010. Epub 2014 Dec 26. J Diabetes Complications. 2015. PMID: 25613093 Free article. Clinical Trial.
Whole-exome sequencing in a Japanese family with highly aggregated diabetes identifies a candidate susceptibility mutation in ADAMTSL3.
Jambaljav B, Tanaka D, Nagashima K, Harashima SI, Harada N, Harada T, Fujiwara Y, Wang Y, Liu Y, Tabara Y, Matsuda F, Koizumi A, Inagaki N. Jambaljav B, et al. Among authors: harada n, harada t. Diabetes Res Clin Pract. 2018 Jan;135:143-149. doi: 10.1016/j.diabres.2017.11.012. Epub 2017 Nov 21. Diabetes Res Clin Pract. 2018. PMID: 29162515
Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.
Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N. Liu Y, et al. Among authors: harada n. FASEB J. 2019 May;33(5):6239-6253. doi: 10.1096/fj.201801783RR. Epub 2019 Feb 21. FASEB J. 2019. PMID: 30789757
., Tokumoto, S., Usui, R., Tatsuoka, H., Tanaka, D., Yabe, D., Harada, N., Hayashi, Y., Inagaki, N. Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion....
., Tokumoto, S., Usui, R., Tatsuoka, H., Tanaka, D., Yabe, D., Harada, N., Hayashi, Y., Inagaki, N. Sphingosine kinase …
2,441 results